Shares of Sino Biopharmaceutical (OTCMKTS:SBMFF – Get Free Report) saw an uptick in trading volume on Thursday . Approximately 2,000 shares were traded during mid-day trading, an increase of 12% from the previous session’s volume of 1,781 shares.The stock last traded at $0.6370 and had previously closed at $0.6439.
Sino Biopharmaceutical Stock Performance
The business has a 50-day moving average price of $0.65 and a 200 day moving average price of $0.77.
About Sino Biopharmaceutical
Sino Biopharmaceutical Limited (OTCMKTS: SBMFF) is a Hong Kong–incorporated investment holding company principally engaged in the pharmaceutical sector. Founded in 2000 and listed on the Hong Kong Stock Exchange in 2006, the company has developed an integrated business model that spans research and development, manufacturing and commercialization of healthcare products. Through its subsidiaries, Sino Biopharmaceutical focuses on enhancing China’s domestic pharmaceutical infrastructure while expanding its footprint across key therapeutic areas.
The company’s product portfolio is organized into three core segments: infusion solutions, small-molecule synthetic pharmaceuticals and innovative biologics.
Further Reading
- Five stocks we like better than Sino Biopharmaceutical
- Dollar Tree’s Turnaround Is Starting to Take Root
- Why Levi’s Digital Strategy Is Paying Off in a Big Way
- Constellation Brands: Beer Growth and Buybacks Mask Stock’s Slump
- Lockheed Martin Secures the Ultimate Defense Moat
Receive News & Ratings for Sino Biopharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sino Biopharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
